Cytokine, chemokine and growth factor expression in the pathogenesis of progressive renal damage

Nephrology

Volumn 3, Issue SUPPL. 2, 1997, Pages s663-s669

  Schena, F Paolo ^a   Grandaliano, Giuseppe ^a   Montinaro, Vincenzo ^a   Ranieri, Elena ^a   Monno, Raffaella ^a   Gesualdo, Loreto ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Chemokine; Cytokine; Growth factor

Indexed keywords

CHEMOKINE; CYTOKINE; GROWTH FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

CELL PROLIFERATION; COMPLEMENT SYSTEM; CONFERENCE PAPER; EXTRACELLULAR MATRIX; GLOMERULONEPHRITIS; GLOMERULOSCLEROSIS; HUMAN; INFLAMMATORY INFILTRATE; INTERSTITIAL NEPHRITIS; KIDNEY FAILURE; KIDNEY FUNCTION; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0030668665     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.1997.tb00282.x     Document Type: Conference Paper

References (46)

1. Ong ACM, Fine LG. Tubular-derived growth factors and cytokines in the pathogenesis of tubulo-interstitial fibrosis: Implications for human renal disease progression. Am. J. Kidney Dis. 1994; 23: 205-9.
2. Van Goor H, Ding G, Kees-Folts D, Grond J, Schreiner GF, Diamond JR. Macrophages and renal disease. Lab. Invest 1994; 71: 456-64.
3. Nathan CF. Secretory products of macrophages. J. Clin. Invest. 1987; 79: 319-26.
4. Stahl RA. Chemoattractants cytokines (chemokines) and immune renal injury. Nephrol. Dial. Transplant 1995; 10: 307-9.
5. Leonard EJ, Yoshimura T. Human monocyte chemoattractant protein-1 (MCP-1). Immunol. Today 1993; 11: 97-101.
6. Satirstein R, Megyesi J, Saggi SJ. Expression of cytokine-like genes JE and KC is increased during renal ischemia. Am. J. Physiol. 1991; 261: F1095-101.
7. Diamond JR, Kees-Folt D, Ding G, Frye JE, Restrepo NC. Macrophages, monocytes chemoattractant peptide-1 and TGF P in experimental hydronephrosis. Am. J. Physiol. 1994; 266: F926-33.
8. Rovin R, Rumancik M, Tan L, Dickerson J. Glomerular expression of Monocyte chemoattractant protein 1 in experimental and human glomerulonephritis. Lab. Invest. 1994; 71: 536-42.
9. Tang WW, Feng L, Mathison JC, Wilson CB. Cytokine expression, upregulation of intercellular adhesion molecule-1, and leukocyte infiltration in experimental tubulo-interstitial nephritis. Lab. Invest. 1994; 70: 631-8.
10. Wenzel UO, Schneider A, Valente AJ, Abboud HE, Thaiss F et al. Monocyte chemotactic protein-1 mediates monocyte/macrophage influx in antithymocyte antibody induced glomerulonephritis. Kidney Int. 1977; 51: 770-6.
11. Tomosugi N, Yamaya H, Kimura S et al. Antisense oligonucleotides tor MCP-1 partially suppress glomerular macrophages infiltration in anti-GBM antibody nephritis (abstract). J. Am. Soc. Nephrol. 1996; 7: 1748.
12. Grandaliano G, Gesualdo L, Ranieri E et al. Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment. J. Am. Soc. Nephrol. 1996; 7: 906-13.
13. Gesualdo L, Grandaliano G, Ranieri E et al. Monocyte recruitment in cryoglobulinemic membrano proliferative glomerulonephritis: a pathogenetic role for monocyte chemotactic peptide-1. Kidney Int. 1997; 53: 155-63.
14. Rother K, Hänsch GM, Rauterberg EW. Complement in inflammation: induction of nephritides and progress to chronicity. Int. Arch. Allergy Appl. Immunol. 1991;94: 23-37.
15. Montinaro V, Serra L, Perissutti S et al. Biosynthesis of C3 by human mesangial cells. Modulation by pro-inflammatory cytokines. Kidney Int. 1995; 47: 829-36.
16. Brooimans RA, Stegman APA, Van Dorp VT et al. Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular cells. J. Clin. Invest. 1991; 88: 379-84.
17. Timmermann JJ, Van Der Woude FJ, Van Gijlswlik-Janssen DJ et al. Differential expression of complement components in human fetal and adult kidneys. Kidney Int. 1996; 49: 730-40.
18. Montinaro V, Ranieri E, Monno R et al. Renal tissue localization of complement C3 in human mesangioproliferative and tubulo-interstitial nephritides (abstract). J. Am. Soc. Nephrol. 1995; 6: 877.
19. Montinaro V, Gesuaido L, Ranieri E et al. Renalcortical complement C3 gene expression in IgA nephropathy. J. Am. Soc. Nephrol. 1997; 8: 415-25.
20. Couser WG, Baker PJ, Adler S. Complement and the direct mediation of immune glomerular injury. Kidney Int. 1985; 28: 879-900.
21. Carpenter G, Cohen S. Epidermal growth factor. Annu. Rev. Biochem. 1979; 48: 193-216.
22. Fisher DA, Salido EC, Barajas L. Epidermal growth factor and the kidney. Annu. Rev. Physiol. 1989; 51: 67-80.
23. Gesualdo L, Di Paolo S, Calabrò A et al. Expression of epidermal growth factor and its receptor in normal and diseased human kidney: An immunohistochemistry and in situ study. Kidney Int. 1996; 49: 656-65.
24. Goodyer PR, Mulligan L, Goodyer CG. Expression of growth-related genes in human fetal kidney. Am. J. Kidney Dis. 1991; 17: 608-10.
25. Safirstein R, Price PM, Saggi S, Harris RC. Changes in gene-expression after temporary renal ischemia. Kidney Int. 1990; 37: 1515-21.
26. Storch S, Saggi S, Megyesi J, Price PM, Safirstein R. Uretral obstruction decreases renal prepro-epidermal growth factor and Tamm-Horsfall expression. Kidney Int. 1992; 42: 89-94.
27. Safirstein R, Zelent AZ, Price PM. Reduced renal prepro-epidermal growth tactor messenger RNA and decreased EGF excretion in ARF. Kidney Int. 1989; 36: 810-15.
28. Ranieri E, Gesuaido L, Petrarulo F, Schena FP. Urinary IL-6/EGF ratio: A useful prognostic marker for the progression of renal damage in IgA nephropathy. Kidney Int. 1996; 50: 1440-7.
29. Floege J, Burns MW, Alpers CE et al. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int. 1992; 41: 297-309.
30. Abboud HE, Grandaliano G, Pinzani M, Pierce GF, Jaffer F. Mitogenic signals for platelet-derived growth factor isoforms in human mesangial cells. J. Cell. Physiol. 1994; 158: 140-50.
31. Abboud HE. Growth factors in glomerulo nephritis. Kidney Int. 1993; 43: 252-67.
32. Alpers CE, Seifert RA, Hudkins KL, Johnson RJ, Bowen-Pope DF. PDGF-receptor localizes to mesangial, parietal epithelial, and interstitial cells in human and primate kidneys. Kidney Int. 1993; 43: 286-94.
33. Knecht A, Fine LE, Kleinman KS et al. Fibroblasts of rabbit kidney in culture. II. Paracrine stimulation of papillary fibroblasts by PDGF. Am. J. Physiol. 1991; 261: F292-9.
34. Gesualdo L, Pinzani M, Floriano J et al. Platelet-derived growth factor expression in mesangial proliferative glomerulonephritis. Lab. Invest. 1991; 65: 160-7.
35. Iida H, Seifert R, Alpers CE et al. Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. Proc. Natl. Acad. Sci. 1991; 88: 6560-4.
36. Gesualdo L, Di Paolo S, Milani S et al. Expression of platelet-derived growth factor receptors in normal and diseased human kidney: An immunohistochemistry and in situ hybridization study. J. Clin. Invest. 1994; 94: 50-8.
37. Johnson RJ, Raines E, Floege J et al. Inhibition of mesangial cell proliferation and matrix expression in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J. Exp. Med. 1992; 175: 1413-6.
38. Isaka Y, Imai E, Kaneda Y et al. Glomerulosclerosis induced by intrarenal in vivo transfection with PDGF or TGF-β genes. J. Clin. invest. 1993; 92: 2597-601.
39. Schena FP, Ranieri E, Montinaro V, Bottalico D, Gesualdo L. Quantification of cytokine mRNA expression in human renal biopsies by reverse transcriptase-polymerase chain reaction (RT-PCR) (abstract). J. Am. Soc. Nephrol. 1992; 3: 664.
40. Roberts AB, McCune BK, Sporn MB. TGF-β: Regulation of extracellular matrix. Kidney Int. 1992; 41: 557-9.
41. MacKay K, Striker LJ, Stauffer JW, Doi T, Agodoa LY, Striker GE. Transforming growth factor β: murine glomerular receptors and responses of isolated glomerular cells. J. Clin. Invest. 1989; 83: 1160-7.
42. Okuda S, Languino LR, Ruoshlati E, Border WA. Elevated expression of transforming growth factor β and proteoglycans production in experimental glomerulonephritis. J. Clin. Invest. 1990; 86: 453-62.
43. Border WA, Okuda S, Languino LR, Sporn MB, Ruoshlati E. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β. Nature 1990; 346: 371-4.
44. Border WA, Noble NA, Yamamoto T et al. Natural inhibitor of transforming growth factor β protects against scarring in experimental kidney disease. Nature 1992; 360: 361-4.
45. Yamamoto T, Nakamura T, Noble N, Ruoshlati E, Border WA. Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc. Natl. Acad. Sci. 1993; 90: 1814-8.
46. Yamamoto T, Noble NA, Cohen AM et al. Expression of transforming growth factor-β in human glomerular diseases. Kidney Int. 1996; 49: 461-9.